Dimensional Fund Advisors LP Sellas Life Sciences Group, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.18 - $3.86 $32,199 - $105,331	-27,288 Reduced 46.57%	31,304 $44,000
Q4 2022 Feb 09, 2023	BUY	$1.8 - $5.41 $105,465 - $316,982	58,592 New	58,592 $138,000
Q2 2022 Aug 12, 2022	SELL	$2.14 - $4.15 $34,077 - $66,084	-15,924 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$8.21 - $10.53 $36,091 - $46,289	-4,396 Reduced 21.63%	15,924 $146,000
Q2 2021 Aug 12, 2021	BUY	$7.19 - $13.71 $35,310 - $67,329	4,911 Added 31.87%	20,320 $226,000
Q4 2020 Feb 25, 2021	BUY	$2.45 - $17.66 $37,752 - $272,122	15,409 New	15,409 $90,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.